請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35236完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 于明暉 | |
| dc.contributor.author | Yi-Hsiu Li | en |
| dc.contributor.author | 李意琇 | zh_TW |
| dc.date.accessioned | 2021-06-13T06:45:01Z | - |
| dc.date.available | 2006-08-04 | |
| dc.date.copyright | 2005-08-04 | |
| dc.date.issued | 2005 | |
| dc.date.submitted | 2005-07-28 | |
| dc.identifier.citation | 1. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002;347:168-74
2. Ming L, Thorgeirsson SS, Gail MH, et al. Dominant role of hepatitis B virus and cofactor role of altatoxin in hepatocarcinogenesis in Qidong, China. Hepatology 2002;36:1214-1220 3. Qian GS, Ross RK, Yu MC, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People’s Republic of China. Cancer Epidemiol Biomarkers Prev 1994;3:3-10. 4. Chen CJ, Yu MW, Liaw YF, et al. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet 1996;59:128-134 5. Donato F, Tagger A, Gelatti U, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002;155:323-331 6. Wang L-Y, You S-L, Lu S-N, et al. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 2003;14:241-250 7. Yuan JM, Govindarajan S, Arakawa K, et al.Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and withes in the U.S. Cancer 2004;101:1009-1017 8. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol. 1994;17:71-9. 9. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56 10. El-Serag HB, Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002;35:S72-S78 11. Chen HL, Chang MH, Hi YH, et al. Seroepidemiology of hepatitis B virus infection in children. JAMA. 1996;276:906-908 12. Chu CJ, Hussain M, Lok ASF. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 2002; 36:1408-1415 13. Magnius LO, Norder H. Subtype, genotype, and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 1995;38:24-34 14. Stuyver L, De Gendt S, Van Geyt C, et al. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness. J Gen Virol 2000;81:67-74 15. Lok AS, Jay H. Special reports and review-management of hepatitis B: 2000 summary of a workshop. Gastrogenterology 2001;120:1828-1853 16. Miyakawa Y, Mizokami M. Classifying Hepatitis B Virus Genotypes. Intervirology 2003;46:329-338 17. Kao JH, Chen PJ, Lai MY, et al. Clinical and virological aspects of blood donors infected with gepatitis B virus genotypes B and C. J Clin Microbiol. 2002;40:22-25 18. Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005;97:265-272 19. Ding X, Mizokami M, Yao G, et al. Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China. Intervirology 2001;44:43-47 20. Sumi H, Yokosuka O, Seki N, et al. Influence of hepatitis B virus genotypes on progression of chronic type B liver disease. Hepatology 2003;37:19-26 21. Kao JH, Chen PJ, Lai MY, et al. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000;118:554-559 22. Nakayoshi T, Maeshiro T, Nakayoshi T, et al. Difference in prognosis between patients infected with hepatitis B virus with genotype B and those with genotype C in the Okinawa Islands: a prospective study. J Med Virol. 2003;70:350-354 23. Chan HLY, Hui AY, Wong ML, et al. Genotype C hepatitis B virus infection is associated with an increases risk of hepatocellular carcinoma. Gut 2004;53:1494-1498 24. Evans AA, O’Connell AP, Pugh JC. et al. Geographic variation in viral load among hepatitis B carriers with differing risk of Hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 1998;7:559-565 25. Tang B, Kruger WD, Chen G, et al. Hepatitis B viremia Is associated with increased risk of hepatocellular carcinoma in chronic carriers. J Med Virol. 2004;72:35-40 26. Ohata K, Hamasaki K, Toriyama K, et al. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Hepatology 2004;19:670-675 27. Ikeda K, Kobayashi M, Saitoh S, et al. Significance of hepatitis B virus DNA clearance and early prediction of hepatocellular carcinogenesis in patients with cirrhosis undergoing interferon thrapy: long-term follow up of a pilot stydy. J Gastroenterol Hepatol 2005;20:95-102 28. Mahmood S, Niiyama G, Kamei A, et al. Influence of viral load and genotype in the progression of hepatitis B-associated liver cirrhosis to hepatocellular carcinoma. Liver international 2005;25:220-225 29. Yu MW, Chang HC, Liaw YF, et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst. 2000;92:1159-64 30. Tai DI, Changchien CS, Hung CS, et al. Replication of hepatitis B virus in first-degree relatives of patients with hepatocellulcar carcinoma. Am. J. Trop. Med. Hyg. 1999;61:716-719 31. Yeh SH, Tsai CY, Kao JH, et al. Quantification and genotyping if hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol 2004;41:659-666 32. Yu MW, Chang HC, Chen PJ, et al. Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan. Int. J. Epidemiol. 2002;33:1008-1015 33. Ikeda K, Saito S, Suzuki Y, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis - a prospective observation of 2215 patients. J Hepatol 1998;28:930-938 34. Stevens CE, Beasley RP, Tsui J, et al. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975;292:771-774 35. Orito E, Ichida T, Sakugawa H, et al. Geographic distribution of hepatitis B virus genotype in patients with chronic HBV infection in Japan. Hepatology 2001;34:590-594 36. Sugavchi F, Chutaputti A, Orito E, et al. Hepatitis B viral genotype and clinical manifestation among hepatitis B carriers in Thailand. J Gastroenterol Hepatol 2002;17:671-676 37. Lee JY, Locarnini S. Hepatitis B virus: pathogenesis, viral intermediates, and viral replication. Clin Liver Dis 2004;8:301-320 38. Suk FM, Lin MH, Newman M, et al. Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in Human Hepatitis B virus. J Virol 2002; 76:12069-12077 39. Marinos G, Torre F, Gunther S, et al. Hepatitis B virus variants with core gene deletion in the evolution of chronic hepatitis B infection. Gastroneterology 1996;111:183-192 40. Moriyama K, Okamoto H, Tsuda F, et al. Reduced precore transcription and enhanced core-pregnome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. Virology 1996;226:269-280 41. Moriyama K. Reduced antigen production by hepatitis B virus harboring nucleotide deletions in the overlapping X gene and precore-core promoter. J Gen Virol 1997;78:1479-1486 42. Buckwold VE, Xu Z, Yen TSB, et al. Effects of a frequent double-nucleotide precursor mutations on hepatitis B virus gene expression and replication. J Gen Virol 1997;78:2055-2065 43. Gunther S, Piwon N, Will H. Wild-type of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653)→T, A(1762) →T and G(1764) →A mutations in the core promoter. J Gen Virol 1998;79:375-380 44. Sterneck M, Kalinina T, Gunther S, et al. Functional analysis of HBV genomes from patients with fulminant hepatitis. Hepatology 1998; 28:1390-1397 45. Lindh M, Hannoun C, Dhillon AP, et al. Core promoter mutation and genotypes in relation to viral replication and liver damage in East Asia hepatitis B virus carriers. J Inf Dis 1999;179:775-782 46. Orito E. Misokami M. Sakugawa H, et al. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotype B and C. Hepatology 2001;33:218-223 47. Peng XM, Huang CM, Li JG, et al. High level of hepatitis B virus DNA after HBeAg-to-anti HBe seroconverdion is related to coexidtence of mutations in its precore and basal core promoter. Would J Gastroenterol 2005;11:3131-3134 48. Li KS, Yamashiro T, Sumie A, et al. Hepatitis B virus B harboring nucleotide deletion in the core promoter region and genotype B correlation with low viral replication activity in anti-HBe positive carriers. J Clin Virol 2001;23:97-106 49. Carman W, Jacyma MR, Hadziyannis S, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989;2:558-591 50. Chen WN, Ooh CJ. Mutations and deletion in core promoter and precore stop codon in relation to viral replication and liver damage in Singaporean hepatitis B virus carriers. Eur J Clin Invest 2000;30:787-792 51. Nayersina R, Fowler P, Giulhots S, et al. HLA A2 restricted cytotoxic T lymphocyte response to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 1993;150:4659-4671 52. Koziel MJ. Cytokine in viral hepatitis. Semin Liver Dis 1999;19:157-169 53. Thursz MR, Kwiatkowski D, Allsopp CEM, et al. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995;332:1065 1069 54. Ahn SH, Han KH, Park JY, et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000;31:1371–1373 55. Hohler T, Gerken G, Notghi A, et al. HLA-DRB1*1301 and 1302 protect against chronic hepatitis B. J Hepatol 2000;26:503–507 56. Thio CL, Thomas DL, Karachi P, et al. Comprehensive analysis of class l and class ll HLA antigens and chronic hepatitis B virus infection. J Virol 2003;77:12083-12087 57. Thio CL, Carrington M, Marti D, et al. Class ll HLA alleles and hepatitis B virus persistence in African Americans. J Infec Dis 1999;179:1004-1006 58. Kohler T, Kruger A, Gerken G, et al. A tumor necrosis factor-alpha (TNF-α) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998;111:579-582 59. Ben-Ari Z, Mor E, Papo O, et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003;98:144-50 60. Zhang PA, Wu JM, Li Y, et al. Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World J Gastroenterol 2005;11:1594-1598 61. Zhang PA, Li Y, Xu P, et al. Polymorphism of interleukin-1B and interleukin-1 receptor antagonist genes with chronic hepatitis B. World J Gastroenterol 2004;10:1826-1829 | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35236 | - |
| dc.description.abstract | 背景:HBV基因型和DNA濃度與肝細胞癌 (Hepatocellulcar carcinoma; HCC)有關。本研究目的在探討HBV基因型及DNA濃度的家族聚集情形;以及這兩種病毒因子的對HCC家族聚集程度的影響。材料方法:研究對象包括280個HCC病例家族,含766位家族成員,210家為散發病例家族(家中僅有一名HCC病例),70家為多發病例家族。以real-time PCR同時進行HBV基因型和DNA濃度測定。統計分析:以多變項線性迴歸模式分析各因子和HBV DNA濃度間的關係;利用unconditional logistic regression估計手足間HBV DNA濃度的concordant odds ratio及其95%信賴區間,利用SAGE 5.0版FCOR程式和uniform weighting scheme分析家族成員間HBV DNA濃度的相關係數。結果:88.2 %的研究家族 (247/280) 其家族成員感染的HBV基因型均相同。HBV基因型分析結果顯示,無論在多發或散發病例家族,HCC病例之基因型C的比例均高於未罹病親屬,特別是在多發病例家族具有顯著差異(p=0.050)。相較於散發病例家族親屬,多發病例家族罹病和未罹病親屬之基因型C的比例均顯著較高。性別 (p=0.048)、HBV基因型 (p=0.003) 及HCC罹病狀態 (p=0.020) 和HBV DNA濃度相關。在控制這些影響HBV DNA濃度的因子後,親子間 (r=0.23, p=0.008) 的相關高於手足的相關 (r=0.14, p=0.020),且以母子間的相關係數最高 (r=0.37, p=0.001),一等親的相關係數在多發或散發病例家族相似。每家隨機選取一對手足進行HBV DNA濃度的一致性分析。以所有研究個案HBV DNA濃度的最高四分位為分組依據(≧6.46 log10 copies/ml),則所有手足的concordant OR為2.12 (95% CI=1.12-4.05),未罹病手足為2.90 (95% CI=1.21-6.93)。結論:HBV基因型具有高度家族聚集,基因型C和HCC家族聚集的程度有關,親子和手足間HBV DNA濃度具顯著相關。 | zh_TW |
| dc.description.abstract | Background Hepatitis B virus (HBV) genotype and DNA levels have been associated with hepatocellular carcinoma (HCC) risk. The aims of this study were to investigate familial correlations for the two viral factors, and to assess whether these factors may influence the degree of familial aggregation of HCC.
Materials and Methods A total of 766 HBV surface antigen-positive individuals were included. These individuals were from 280 families ascertained through a HCC proband, including 210 simplex and 70 multiplex families (defined as having an additional patient with HCC among first-degree relatives of the proband). We used real-time polymerase chain reaction assays of plasma DNA samples to quantify HBV DNA levels and determine HBV genotype for all subjects. Multiple linear regression was used to assess correlations between various factors and HBV DNA levels. Unconditional logistic regression was used to estimate sibling concordant odds ratios and their 95% confidence intervals (CIs) for HBV DNA levels. Familial correlation was calculated with use of the uniform weighting scheme as implemented in the FCOR program of SAGE version 5.0. Results For 247 (88.2%) of the 280 families, all family members were infected with the same HBV genotype. The prevalence of genotype C HBV was higher in affected than in unaffected individuals; this difference was statistically significant in multiplex families (P=0.05). Multiplex families had a higher prevalence of genotype C than simplex families. Gender (P=0.048), HBV genotype (P=0.003), and HCC status (P=0.020) were significantly associated with HBV DNA levels. After adjusting for gender, HBV genotype, and HCC status, HBV DNA levels showed higher parent-offspring (r=0.23, P=0.008) and lower sibling correlations (r=0.14, P=0.020). Particularly, the mother-son correlation coefficient reached 0.37 (P=0.001). When 6.46 log copies/mL was used as the cutoff point to classify the data, we obtained a sibling concordant odds ratio of 2.12 (95% CI=1.12-6.93) for all sib pairs (including affected-unaffected discordant pairs), and 2.90 (95% CI=1.21-6.93) for unaffected sib pairs. Conclusions We found strong familial correlation for HBV genotype. There were significant parent-offspring and sibling correlations for HBV DNA levels. Genotype C was associated with the degree of familial aggregation of HCC. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T06:45:01Z (GMT). No. of bitstreams: 1 ntu-94-R92842009-1.pdf: 359610 bytes, checksum: a34ba84958d5c23814f257c91f6aff0f (MD5) Previous issue date: 2005 | en |
| dc.description.tableofcontents | 中文摘要.................................................................................1
英文摘要.................................................................................2 前言....................................................................................3-7 研究材料與方法.………………………………………………………………8-10 結果……………….…………………………………………………………….11-13 討論……………….…………………………………………………………….14-18 參考文獻……….………………………………………………………………19-25 附錄圖表 表一:研究個案之人口學特徵…………………………………………….26 表二:研究個案HBV病毒特徵……………………………………………27 表三:766研究個案HBV DNA濃度之多變項線性迴歸模式……28 表四:280家HBV基因型分佈……………………………………………29 表五:家族親屬間HBV DNA濃度相關性分析……………………….30 表六:配對手足HBV DNA濃度的相關性分析……………………….31 圖一:HBV DNA濃度分佈………………………………………………….32 | |
| dc.language.iso | zh-TW | |
| dc.subject | 基因型 | zh_TW |
| dc.subject | 家族相關分析 | zh_TW |
| dc.subject | DNA濃度 | zh_TW |
| dc.subject | B型肝炎 | zh_TW |
| dc.subject | 肝細胞癌 | zh_TW |
| dc.subject | HCC | en |
| dc.subject | HBV | en |
| dc.subject | familial correlation | en |
| dc.subject | viral load | en |
| dc.subject | genotype | en |
| dc.title | B型肝炎病毒基因型與DNA濃度的家族相關分析 | zh_TW |
| dc.title | Familial correlation of hepatitis B virus genotype and DNA loads | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 93-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 李文宗,范盛娟,簡國龍,戴政 | |
| dc.subject.keyword | B型肝炎,肝細胞癌,基因型,DNA濃度,家族相關分析, | zh_TW |
| dc.subject.keyword | HBV,genotype,viral load,familial correlation,HCC, | en |
| dc.relation.page | 32 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2005-07-29 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 流行病學研究所 | zh_TW |
| 顯示於系所單位: | 流行病學與預防醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-94-1.pdf 未授權公開取用 | 351.18 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
